All In Biotech

Free tool

FAERS Monitor: Zoryve

The FDA Adverse Event Reporting System collects reports from patients, clinicians and manufacturers. Counts are unverified reports, not rates: they rise with how widely a drug is used, how long it has been sold and media attention, a report can name several drugs, and a report does not show the drug caused the event.

Last checked: Nov 20, 2026FDA FAERS (openFDA) last updated: Oct 28, 2026Methods & limitations

Reports naming NDA 215985 or its brand name (Zoryve, Roflumilast). Reports on generic versions are filed under their own applications.

Reports

3,191

Serious

1,832

57% of reports

Hospitalization

1,067

Death reported

198

Any cause; not necessarily from the drug

Most reported reactions

MedDRA preferred terms.

  • dyspnoea467
  • drug ineffective293
  • off label use272
  • chronic obstructive pulmonary disease251
  • diarrhoea239
  • pneumonia229
  • asthma215
  • cough205
  • nausea191
  • headache179
  • wheezing169
  • pruritus161
  • therapeutic product effect incomplete160
  • weight decreased142
  • condition aggravated139

Reports by year received

View as table
YearReports
20113
2012178
2013221
2014203
201576
201628
201732
201873
201981
202088
2021100
2022116
2023235
2024398
2025650
2026709

Disproportionality screen

Proportional reporting ratio (PRR): how much more often each reaction appears in this drug's reports than in the other 21,050,968 FAERS reports. Flagged when PRR is at least 2, chi-squared at least 4 and there are 3 or more reports (Evans criteria). A screening statistic only.

ReactionReportsPRR95% CI lowerChi-squared
chronic obstructive pulmonary diseaseSignal25131.928.37,453
wheezingSignal16918.816.32,836
therapeutic product effect incompleteSignal16014.912.82,056
asthmaSignal21512.611.02,284
dyspnoeaSignal4675.45.01,734
coughSignal2054.84.2625
pneumoniaSignal2294.74.1665
weight decreasedSignal1423.42.9235
condition aggravatedSignal1393.02.6188
pruritusSignal1612.82.4182
diarrhoeaSignal2392.42.2208
off label useSignal2722.01.8151
headache1791.91.675
nausea1911.61.443
drug ineffective2931.51.346

A high PRR for a reaction that is also the condition being treated (for example "disease progression" for a cancer drug) is expected and is not a safety signal.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.